Christopher Brett Primiano, EVP, CBO, GC & Secretary at Karyopharm Therapeutics Inc. (KPTI), sold 16,374 shares at $19.62 ($322K) on 2020-05-07, disclosed to the SEC on 2020-05-11.
Open-market sale of $322k KPTI by EVP, CBO, GC & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.62 | 6,714 | $132K | 40.9% |
| 2 | $19.62 | 6,714 | $132K | 40.9% |
| 3 | $20.00 | 2,946 | $59K | 18.3% |
| Total | $19.69 avg | 16,374 | $322K | 100% |
| Filing → |
| KPTI | SELL | 2020-10-14 | $1.3M | — | Filing → |
| KPTI | SELL | 2020-09-10 | $301K | — | Filing → |
| KPTI | SELL | 2020-03-04 | $672K | — | Filing → |